Skip to main content

Table 4 Univariate and multivariate logistic regression to the estrogen receptor (ER) and progesterone receptor (PR) positive breast cancer

From: The association between serum lipid levels and histological type of breast cancer

Variables

Univariate

Multivariate

Model 1

Model 2

OR (95%CI)

P

OR (95%CI)

P

OR (95%CI)

P

WHO grade (I&II vs III)

0.24 (0.13–0.43)

 < 0.001

0.23 (0.11–0.47)

 < 0.001

0.23 (0.11–0.47)

 < 0.001

Long diameter(≤ 5 cm vs > 5.0 cm)

0.56 (0.23–1.17)

0.12

0.50 (0.20–1.25)

0.14

0.52 (0.21–1.31)

0.17

HDL-c(≤ 1.36 vs > 1.36)

0.46 (0.23–0.94)

0.03

0.49 (0.21–1.16)

0.047

0.39 (0.17–0.91)

0.03

LDL-c(≤ 2.08 vs > 2.08)

0.25 (0.07–0.87)

0.03

0.28 (0.08–1.04)

0.05

0.22 (0.06–0.85)

0.03

TC (≤ 5.12 vs > 5.12)

1.06 (0.53–2.13)

0.87

    

TG (≤ 1.52 vs > 1.52)

2.15 (0.98–4.74)

0.06

    

ApoA (≤ 1.34 vs > 1.34)

0.76 (0.41–1.41)

0.39

    

ApoB (≤ 0.76 vs > 0.76)

0.70 (0.35–1.40)

0.32

    

LP(a) (≤ 33 vs > 33)

0.49 (0.22–1.09)

0.08

    

ApoE (≤ 4.7 vs > 4.7)

0.78 (0.40–1.53)

0.47

    

HDL/TC (≤ 0.29 vs > 0.29)

0.53 (0.26–1.08)

0.08

    

LDL/TC (≤ 0.64 vs > 0.64)

0.66 (0.35–1.23)

0.19

    

ApoA/ApoB(≤ 1.22 vs > 1.22)

0.67 (0.32–1.41)

0.29

    

HDL/ApoA (≤ 1.09 vs > 1.09)

0.54 (0.27–1.06)

0.07

    

LDL/ApoB (≤ 2.66 vs > 2.66)

2.18 (0.91–5.18)

0.08

    
  1. Model 1 included HDL, LDL, long diameter and WHO grade; Model 2 was additionally adjusted with age and body mass index
  2. HDL-c high-density lipoprotein-cholesterol, LDL-c low-density lipoprotein-cholesterol, TC total cholesterol, TG triglyceride, ApoA apolipoprotein A, ApoB apolipoprotein B, ApoE apolipoprotein E, LP lipoprotein